As a fixed-dose combination, CagriSema was assessed in two phase 3 studies (REDEFINE 1 and 2), resulting in significant and clinically relevant reductions in body weight compared with placebo in adults with overweight or obesity, with [8] or without type 2 diabetes [9]
Voyvodic PL, Min D, Liu R, Williams E, Chitalia V, Dunn AK, Baker AB
10.1097/ICO.0b013e31821dd986 143 TurkovicB.SikiricP.SeiwerthS.MiseS.AnicT.PetekM.et al (2004)
Its a scientifically established standard for safety and efficacy
If any signs of injection site infection develop (increasing redness, warmth, swelling, or pain), discontinue use and consult a healthcare provider
A Powerful Partnership For Your Overall Well-Being The real magic of combining semaglutide with B12 is that it creates a more complete, supportive experience